MediciNova stock trades at USD 2.88 with Q2 cash at USD 25.4 million

Published on 09/23/2026 at 20:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

MediciNova stock stood 26.15 percent below its 52-week high on September 23, 2026. Q2 revenue rose 145.2 percent to USD 458,439, while net loss narrowed.

MediciNova stock, biotechnology, clinical-stage pharmaceuticals, Q2 2026 results, Nasdaq, Illustration mit AI erstellt.

MediciNova stock (ISIN US58468P2065) traded at USD 2.88 on Nasdaq on September 23, 2026, down 0.52 percent from the prior close. The clinical-stage biotechnology company entered the session with USD 25.4 million in cash after the second quarter and no debt, according to Investing.com.

Cash position shapes the runway

The cash balance of USD 25.4 million at June 30, 2026, gives the balance sheet greater weight than near-term revenue. The company reported no debt and no warrants outstanding in the September 11 conference transcript cited by Investing.com.

MediciNova's Q2 2026 revenue reached USD 458,439, compared with USD 186,984 in Q1. That represents a 145.2 percent quarter-over-quarter increase, although the absolute revenue base remains small for a biotechnology company.

Clinical pipeline remains central

MediciNova is developing small-molecule therapies for severe diseases, with MN-166, also known as ibudilast, among its leading programs. The pipeline includes research in amyotrophic lateral sclerosis, progressive multiple sclerosis, degenerative cervical myelopathy and other neurological conditions.

The company said on September 8, 2026, that it would participate in two investor conferences during September, according to its MediciNova investor release. For investors, the combination of clinical milestones and cash usage is more relevant than the latest revenue increase alone.

Stock remains below yearly peak

At USD 2.88 on September 23, 2026, MediciNova stock was 26.15 percent below its 52-week high of USD 3.90 and 146.15 percent above its 52-week low of USD 1.17. The daily trading range was USD 2.85 to USD 3.02, placing the latest quote inside a volatile one-year band.